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The relationship between extent of
hemoglobin purification and the performance
characteristics of a blood-based flocculant†
Rafael A Garcia,* Lorelie P Bumanlag and George J Piazza
Abstract
BACKGROUND: Whole blood is a highly complex substance. Hemoglobin, the most abundant blood protein, can function as a
flocculant; most of the other blood components exhibit poor flocculant activity. For the purpose of processing rawwhole blood
into a flocculant product, the practical value of hemoglobin purification is uncertain.
RESULTS: This study compares the flocculant performance of whole blood to that of three different semi-purified hemoglobin
preparations. The whole blood is processed to remove the plasma proteins, the solid cell components, or both. The flocculant
performanceofwhole blood andeachhemoglobin preparation is comparedoverwide ranges of flocculant dose and suspension
pH.Theclarified liquidsareexamined for increases inchemicaloxygendemandandKjeldahlnitrogen.Hemoglobinpreparations
that excluded plasma gave peak flocculation performance at approximately 30 mg solids per gram of suspended kaolin, and
gave greatly reduced performance at higher doses; preparations that included plasma gave very similar peak performance, but
alsomaintained relatively high performance at doses up to at least 200mg g−1.
CONCLUSION: It is shown that removal of the plasma and the cell solids does not improve the flocculant performance or lessen
the residual pollutants in the treated water.
Published 2017. This article is a U.S. Government work and is in the public domain in the USA.
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INTRODUCTION
Blood is a by-product of meat production which is typically col-
lected and processed to produce an animal feed ingredient.1
Recent research has demonstrated that blood and blood compo-
nents can serve as bio-based substitutes for synthetic polymer
flocculants such as polyacrylamide. Blood-based flocculants are
highly effective at clarifying colloidal suspensions of kaolin clay2
and lignin.3
The blood of vertebrate animals is an exceedingly complex sub-
stance, but it is primarily red blood cells suspended in plasma. The
red blood cells are essentially capsules containing a concentrated
solution of hemoglobin (Hb), which is by far the most abundant
blood protein.4 The red cells of non-mammalian vertebrates, such
as poultry species, also contain a nucleus.5 Plasma is an aqueous
solution of many substances, predominantly the proteins serum
albumin, various globulins and fibrinogen.6
Piazza et al.7 studied the most abundant blood proteins individ-
ually, in order to identify the components of blood responsible for
its flocculation activity. Hb was found to have the greatest activ-
ity. Serum albumin, the second most abundant blood protein, did
not display any flocculation activity. Particular plasma globulins
displayed flocculation activity almost as high as Hb, but they are
present in much lower concentrations. Fibrinogen, which is typi-
cally about 4% of total plasma protein, had moderate flocculant
activity.
Isolation of a relatively pure solution of Hb for use as a flocculant
is not technically challenging. The red cells can be separated from
theplasmaby settlingor centrifugation. The cells can thenbe lysed
by physical or chemical means to release their contents. Finally,
the solid cell debris, including the cell membrane and possibly the
nuclei, can be removed by centrifugation or filtration.
It is not clear, however, that isolating Hb from the other blood
components is actually advantageous. Compared to whole blood,
Hb isolatemay be amore potent flocculant because the less effec-
tive components are removed; indeed, a previous study8 com-
pared bovine whole blood and commercially produced Hb and
found that the Hb was more effective on a total solids basis. Also,
removing components that do not have flocculant propertiesmay
minimize the amount of blood substances that remain in the
treated water, contributing to undesirable wastewater character-
istics such as turbidity, chemical oxygen demand (COD) and total
Kjeldahl nitrogen (TKN).9 On the other hand, each unit operation
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of an Hb isolation process contributes capital and operating costs,
and any components removed from the blood, such as plasma,
may have to be disposed of at a financial or environmental cost.
The present study examines these tradeoffs and attempts to pro-
vide a rational basis for determining whether or not Hb should be
isolated for the purpose of producing blood-based flocculant.
EXPERIMENTAL
Source and collection of blood
Chicken blood was collected on the slaughter line of a chicken
processing plant as described previously.9 Briefly, blood from
slaughtered birds flowed from neck incisions into plastic trays
containing a concentrated solution of dipotassium ethylenedi-
amineteteraacetic acid (EDTA), which inhibits coagulation and
microbial activity;10 the final concentration of EDTA in blood was
15 mmol L−1. The blood was filtered through a nylon mesh screen
to exclude any large debris. This blood, treated with anticoagulant
and filtered, will be referred to aswhole blood.
Preparation of flocculant product variants
Hb isolate product was produced by subjecting whole blood to
a series of three operations (Table 1, product variant E). To elimi-
nate plasma, whole blood was centrifuged at 5000× g for 30 min
in a swinging bucket rotor to pellet the cells; the supernatant
plasmawas drawnoff anddiscarded. The pelleted cells were resus-
pended in isotonic saline and washed by repeatedly centrifuging,
discarding the supernatant and resuspending in fresh saline. To
rupture the cells and release the Hb-rich cell contents, the cells
were subjected to ultrasonic processing in 25 mL batches using
an S-4000 ultrasonic liquid processor (Misonix, Farmingdale, NY,
USA) fittedwith amicrotip probe and operating at 40% amplitude.
The sonicator was programmed to run in 2 s intervals, with 2 s
pauses between intervals, while incubating in an ice-water bath.
To remove solid cell debris, the sonicated liquid was centrifuged
at 17 000× g for 10 min; the supernatant cell content component
was drawn off and saved.
Product variants were produced by omitting one or two of
the processing steps (Table 1, product variants A, B and D). As
a consequence of these process variations, each product variant
retains a different combination of the components of the whole
blood. Product variant Cwas different from the others in that it was
just plasma, and does not have any of the Hb-rich cell contents;
it was included to provide an additional point of comparison.
Multiple aliquots of each product variant were stored frozen until
use. Any particular aliquot was frozen and thawed only once.
Analysis of product variants
Hemoglobin (Hb)
Hb was quantified using a modern version of the cyanmethe-
moglobin method.11 Prepared Drabkin’s reagent was obtained
from Sigma (St Louis, MO, USA), and the assay was carried out
according to the product literature.12 Cyanmethemoglobin stan-
dardwas obtained fromStanbio Laboratory (Boerne, TX, USA). Five
replicate determinations were conducted for each sample type.
Total solids (TS)
TS content of blood product variants was determined by oven
drying of samples to constant mass. Analyses were replicated
four times.
Table 1. Whole bloodwas processed in variousways to give product
variants A–E. The variants differ in the particular blood components
that have been retained in the product
Processing
applied
Blood components
in product
Product
variant
Wash
cells
Rupture
cells
Centrifuge
solids Plasma
Cell
contents
Cell
solids
A x x x x
B x x x x
C xS x
D xP x x x
E xP x x x
xS, supernatant plasma retained, cell pellet discarded.
xP, cell pellet retained, supernatant discarded.
Flocculation effectiveness
The flocculant effectiveness of the blood products was measured
using amethod developed and validated by this laboratory,13 with
some variations. Briefly, fine kaolin clay is suspended in a buffer
solution and the turbidity of this suspension is determined before
and after flocculant treatment. The flocculant treatment involves
adding flocculant to the suspension, subjecting the suspension to
a controlledmixingprogram, followedbydegassingof the suspen-
sion, and, finally, quiescent settling under temperature-controlled
conditions. The initial turbidity (T i) and final turbidity (T f) of each
vial is used to determine the kaolin clarification effectiveness (KCE)
at each concentration, which is computed as follows:
KCE(s.c.) = log10
(
Ti
Tf
)
(1)
In thepresent study, small changes to the referencedmethodwere
adopted. In order to minimize the contribution of the suspension
buffer to COD, the standard 25 mmol L−1 malic–MES–Tris (MMT)
buffer was altered; in experiments with varying pH, 10 mmol
L−1 MMT was used; in experiments with varying doses of blood
product, 3mmol L−1 malate buffer was used. All experiments used
a kaolin concentration of 1 g L−1 rather than 3g L−1, as this reduced
interference with the analytical methods employed. All flocculant
treatments were tested in quadruplicate.
Analysis of treated suspensions
Samples for chemical analysis of treated suspensions were drawn
from 3 cm below the liquid surface using a pipette.
Chemical oxygen demand
COD was determined according to SM 5220 D.14 The analysis
was conducted using pre-filled TNTplus COD reagent vials (Hach,
Loveland, CO, USA) and a spectrophotometer specialized for this
test format (model DR 3900, Hach). COD due to the suspension
buffer was measured separately and this value was subtracted
from the measured COD of treated suspensions.
Total Kjeldahl nitrogen (TKN)
TKN was determined using s-TKN test kits (Hach). These test
kits, although they do not actually employ traditional Kjeldahl
chemistry, are an EPA-accepted alternative for TKN determination.
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Table 2. Hemoglobin (Hb) and total solids (TS) concentrations for
product variants. Results are± 1 standard deviation. Hb/TS is themass
ratio of Hb to TS; standard deviation of Hb/TS was computed using an
appropriate propagation of error formula
Product variant Hb (mg/mL) TS (mg/mL) Hb/TS b
A 97.3 ± 2.0 192.4 ± 0.7 0.51 ± 0.01a
B 99.8 ± 3.8 181.7 ± 4.6 0.55 ± 0.03a
C n.d.a 84.6 ± 3.2
D 91.8 ± 2.6 127.5 ± 2.7 0.72 ± 0.03b
E 101.2 ± 3.1 116.6 ± 1.6 0.87 ± 0.03c
a None detected.
b Results followed by a common letter are not significantly different at
the 95% confidence level.
RESULTS ANDDISCUSSION
The blood product variants were intended to differ in composi-
tion due to the removal or retention of plasma and cell solids.
Total solids is the concentration of all non-volatile dissolved and
suspended substances in an aqueous liquid. The ratio of Hb con-
centration to TS (Hb/TS) can be taken as ameasure of theHbpurity
in a product variant.
The variants without plasma (D and E) had much greater Hb/TS
than those in which plasma was retained (A and B) (Table 2). The
variants without cell solids (B and E) had slightly greater Hb/TS
than their corresponding variants that retained cell solids (A and
D, respectively), although the difference between A and B was
not statistically significant. Variant C, which is simply plasma, did
not have a detectable concentration of Hb, as would be expected
unless the red blood cells were lysing prematurely.
When added to a solution with suspended kaolin, each of the
product variants caused some of the kaolin to flocculate, reducing
the turbidity of the suspension. The Hb-containing variants (A,
B, D and E), however, were much more effective than plasma (C)
(Fig. 1a).Most of the reduction in turbidity occurred in thefirst hour
after dosingwith flocculant, andwith further small reductions over
at least the next 5 h.
Comparing the effect of flocculants on a linear scale of turbidly
has somewhat limited utility because in some applications very
little turbidity is acceptable; in drinking water, for example, many
jurisdictions have turbidity limits of 1–5 nephelometric turbidity
units (NTU), and prefer to produce water that has about 0.1 NTU.
The meaningful difference between 1 and 0.1 NTU is not clearly
shown on a linear scale. Consequently, the remaining results are
presented in terms of KCE, a logarithmic scale in which a result of 1
represents a 90% reduction in the initial turbidity, a result of 2 rep-
resents a 99% reduction, and so on. Replotting the settling time
results in terms of KCE (Fig. 1b) shows that for the Hb-containing
samples the settling that occurs after the initial hour results in an
additional log-reduction in turbidity, a result that may be mean-
ingful to end-users of the flocculant. Further, the KCE results are
suggestive that the variants containing solid cell debris (A and D)
clarify more rapidly that their counterpart solid-free variants (B
and E).
The dose dependence of KCE is quite different for the
plasma-free (D and E) and plasma-containing (A and B) vari-
ants (Fig. 2). The plasma-free variants initially produced higher
KCE with increasing dose up to a maximum, past which further
increases in dose produced lower KCE. This is consistent with a
known phenomenon observed when suspended particles are
treated with a polymer.15 At low polymer concentration, the
polymer covers only part of a particle’s surface; polymer adsorbed
on one particle can form a bridge between particles by adsorbing
to a bare spot on another particle. At higher concentration, the
polymer covers the entire particle surface, and steric interference
inhibits coalescence of suspended particles.
The plasma-containing variants produced similar results at low
doses, but markedly different results at higher doses. Higher
doses produced KCE modestly lower than the peak KCE for these
variants; the dose could be increased at least fourfold over the
optimum dose without having a major negative impact on KCE.
This result could be important in flocculant applications where
the concentration of suspended particles is unknown or highly
variable; suspensions could be overdosedwith plasma-containing
variants with little risk of flocculation failure.
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Figure 1. Clarification of a kaolin suspension over time, after being dosed with a blood flocculant product variant, in terms of (a) turbidity and (b) kaolin
clarification effectiveness (KCE). Data points represent means of four replicate experiments and error bars represent ± 1 standard deviation.
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Figure 2. Kaolin clarification effectiveness (KCE) of flocculant product
variants by flocculant dose at 6 h post treatment. Data points represent
means of four replicate experiments and error bars represent± 1 standard
deviation.
The reason for the difference in the KCE of plasma-containing
and plasma-free variants is not clear. Plasma by itself (C) pro-
duces some flocculation at high doses. This may be due to the
ionic strength of the plasma reducing the electrostatic repulsion
between the kaolin particles, or it may be some phenomenon
caused by the plasma proteins.
The previously reported decline in KCE for whole blood or Hb
when used at pH greater that 5.516 was mirrored in experiments
using the product variants over a wide pH range (Fig. 3). This
decline is thought to be related to a change in ionization state of
Hb amino acid side chains, although this is not well understood.
Hypothetically, the presence of plasma proteins with ionization
characteristics different from Hb could mitigate this effect, allow-
ing the product to be used at higher pH. This turns out not to be
the case. The performance of variant C declines more rapidly with
pH compared to the Hb-containing variants. The pH dependence
of the Hb-containing variants did not differ from one another in a
systematic manner.
When added to a solution without suspended kaolin, the blood
product variants all made substantial contributions to negative
water quality characteristics, including turbidity, TKN and COD,
even when used at the low levels that would be appropriate for
a blood-based flocculant (Table 3). It was anticipated that prod-
uct variants containing cell solids (A and D) would contribute
more turbidity than the corresponding solids-free variants (B and
E), but the results do not support this. Rather, plasma seems to
be responsible for more than half of the turbidity; both variants
containing plasma (A and B) were much more turbid than those
without plasma (D and E). Plasma-free variants (D and E) con-
tributed much less to COD and TKN than their plasma-containing
counterparts (A and B), as expected. Other important wastewater
characteristics, including total suspended solids, total phosphate,
fat oil and grease, and ammonia, were not measured; previous
results9 indicate that whole blood would not contribute substan-
tial concentrations of these pollutants when used in quantities
relevant for the flocculant application. Whole blood and blood
product variants are expected to make major contributions to
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Figure 3. Effect of pH on kaolin clarification effectiveness (KCE) of product
variants dosed at 50mgg−1 kaolin and allowed to settle for 6 h. Data points
represent means of four replicate experiments and error bars represent ±
1 standard deviation.
Table 3. Impact of adding 500 ppm (v/v) product variants on water
quality in the absence of kaolin. Control is buffer with no added blood
product. Chemical oxygen demand (COD) results are the difference
between the measured value and the value for a control sample of
buffer with no added blood product. Values are means ± 1 standard
deviation of 3–4 replicate experiments
Product Turbidity TKN COD
variant (NTU) (mg L−1) (mg L−1)
control 0.3 ± 0.2 0.6 ± 0.6 0.0 ± 1.8
A 11.4 ± 0.5 11.6 ± 0.2 118.5 ± 4.8
B 15.0 ± 2.0 7.4 ± 0.4 117.2 ± 3.4
C 8.4 ± 2.7 2.3 ± 0.2 34.3 ± 8.0
D 5.5 ± 2.9 4.9 ± 0.6 70.7 ± 4.0
E 4.9 ± 0.4 6.7 ± 0.7 78.1 ± 4.5
biochemical oxygen demand (BOD), which was not determined
in this study; while BOD and COD are different, they are similar
enough that it can reasonably be expected that, if BOD had been
determined, the valueswould followapattern very similar to those
found for COD.
When added to a kaolin suspension, the blood product variants
may contribute TKN and COD to the clarified water remaining
after solid particles are allowed to flocculate and settle. The results
from testing both COD and TKN over a wide range of doses are
very similar, suggesting that most of the COD in the product
variants is due to protein (Fig. 4). In the dose range where all of
the Hb-containing variants gave high KCE results, approximately
15–60 mg TS g−1 kaolin, neither the COD nor the TKN of the
clarified water was increased substantially. As described in the
Methods section, the COD results reported are the difference
between the measured COD and the COD of buffered suspension
with no added flocculant; this accounts for the slightly negative
COD reported, that is, no analysis actually produced a direct result
that was a negative value for COD. At doses greater than 75
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Figure 4. Dose of various flocculant product variants versus pollutant concentration of the treated suspension: (a) chemical oxygen demand (COD) and
(b) total Kjeldahl nitrogen (TKN) were determined using samples taken from treated suspension 6 h post-flocculant dosing. COD values are corrected for
buffer contribution to COD. Data points represent means of four replicate experiments and error bars represent ± 1 standard deviation.
mg TS g−1 kaolin both the COD and TKN of treated water rise
substantially. The data are suggestive of a more gradual increase
in these values for plasma-containing variants (A and B), but
the results from high product doses had too much variability to
demonstrate this clearly.
CONCLUSIONS
Based on the aspects of flocculation performance examined in this
study, there is no evidence that Hb is superior to whole blood.
Rather, blood product variants containing plasma were much less
sensitive to thenegative effects of flocculant overdose. Inclusionof
blood components other than Hb did not lead to excessive levels
of pollutants.
Although this study did not examine processing costs, it is clear
that the processing required to isolate Hb cannot be justified in
terms of flocculant performance. Some issues unrelated to perfor-
mance, and not examined in this study, may still be important to
process design, including energy required todehydrate eachprod-
uct variant, the impact of processing on pathogen inactivation or
by-product disposal cost.
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